Analysis of the serum bile acid composition for differential diagnosis in patients with liver disease

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Sugita, Tomonori ^a   Amano, Katsushi ^a   Nakano, Masanori ^a   Masubuchi, Noriko ^b   Sugihara, Masahiro ^b   Matsuura, Tomokazu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

12 KETOLITHOCHOLIC ACID; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; GLYCOLITHOCHOLIC ACID; GLYCOURSODEOXYCHOLIC ACID; GUANOSINE TRIPHOSPHATE; LITHOCHOLIC ACID; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILE COMPOSITION; BILIARY TRACT DISEASE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PROTHROMBIN TIME; TANDEM MASS SPECTROMETRY;

EID: 84925423480     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/717431     Document Type: Article

References (26)

1. A. Pellicoro and K. N. Faber, "Review article: the function and regulation of proteins involved in bile salt biosynthesis and transport, " Alimentary Pharmacology and Therapeutics, vol. 26, supplement 2, pp. 149-160, 2007.
2. J. M. Ridlon, D.-J. Kang, and P. B. Hylemon, "Bile salt biotransformations by human intestinal bacteria, " Journal of Lipid Research, vol. 47, no. 2, pp. 241-259, 2006.
3. C. N. Falany, M. R. Johnson, S. Barnes, and R. B. Diasio, "Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase, "The Journal of Biological Chemistry, vol. 269, no. 30, pp. 19375-19379, 1994.
4. I. Burkard, A. von Eckardstein, and K. M. Rentsch, "Differentiated quantification of human bile acids in serum by highperformance liquid chromatography-tandem mass spectrometry, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 826, no. 1-2, pp. 147-159, 2005.
5. S. E. Lucangioli, G. Castano, M. D. Contin, and V. P. Tripodi, "Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment, " Annals of Clinical Biochemistry, vol. 46, no. 1, pp. 44-49, 2009.
6. L. Ye, S. Liu, M. Wang, Y. Shao, and M. Ding, "High-performance liquid chromatography-tandemmass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 860, no. 1, pp. 10-17, 2007.
7. D. Joshi, A. James, A. Quaglia, R. H. Westbrook, and M. A. Heneghan, "Liver disease in pregnancy, " The Lancet, vol. 375, no. 9714, pp. 594-605, 2010.
8. S. P. R. Bathena, S. Mukherjee, M. Olivera, and Y. Alnouti, "The profile of bile acids and their sulfatemetabolites in human urine and serum, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 942-943, pp. 53-62, 2013.
9. X. Xiang, Y. Han, M. Neuvonen, J. Laitila, P. J. Neuvonen, and M. Niemi, "High performance liquid chromatographytandem mass spectrometry for the determination of bile acid concentrations in human plasma, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 1, pp. 51-60, 2010.
10. I. Makino, H. Hashimoto, K. Shinozaki, K. Yoshino, and S. Nakagawa, "Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases, " Gastroenterology, vol. 68, no. 3, pp. 545-553, 1975.
11. J. Trottier, A. Bialek, P. Caron et al. , "Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a Pilot Study, " Digestive and Liver Disease, vol. 44, no. 4, pp. 303-310, 2012.
12. G. Xie, W. Zhong, H. Li et al. , "Alteration of bile acidmetabolism in the rat induced by chronic ethanol consumption, " The FASEB Journal, vol. 27, no. 9, pp. 3583-3593, 2013.
13. V. Purohit, J. C. Bode, C. Bode et al. , "Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, andmedical consequences: summary of a symposium, " Alcohol, vol. 42, no. 5, pp. 349-361, 2008.
14. G. Corrao, P. Ferrari, A. Zambon, and P. Torchio, "Are the recent trends in liver cirrhosis mortality affected by the changes in alcohol consumption? Analysis of latency period in European countries, " Journal of Studies on Alcohol, vol. 58, no. 5, pp. 486-494, 1997.
15. C. J. Sinal, M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, and F. J. Gonzalez, "Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis, " Cell, vol. 102, no. 6, pp. 731-744, 2000.
16. D. Duran-Sandoval, B. Cariou, F. Percevault et al. , "The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition, " The Journal of Biological Chemistry, vol. 280, no. 33, pp. 29971-29979, 2005.
17. K. Ma, P. K. Saha, L. Chan, and D. D. Moore, "Farnesoid X receptor is essential for normal glucose homeostasis, " Journal of Clinical Investigation, vol. 116, no. 4, pp. 1102-1109, 2006.
18. S. Cipriani, A. Mencarelli, G. Palladino, and S. Fiorucci, "FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats, " Journal of Lipid Research, vol. 51, no. 4, pp. 771-784, 2010.
19. C. Thomas, A. Gioiello, L. Noriega et al. , "TGR5-mediated bile acid sensing controls glucose homeostasis, " Cell Metabolism, vol. 10, no. 3, pp. 167-177, 2009.
20. M. Makishima, A. Y. Okamoto, J. J. Repa et al. , "Identification of a nuclear receptor for bite acids, " Science, vol. 284, no. 5418, pp. 1362-1365, 1999.
21. D. J. Parks, S. G. Blanchard, R. K. Bledsoe et al. , "Bile acids: natural ligands for an orphan nuclear receptor, " Science, vol. 284, no. 5418, pp. 1365-1368, 1999.
22. T. Maruyama, Y. Miyamoto, T. Nakamura et al. , "Identification of membrane-type receptor for bile acids (M-BAR), " Biochemical and Biophysical Research Communications, vol. 298, no. 5, pp. 714-719, 2002.
23. Y. Kawamata, R. Fujii, M. Hosoya et al. , "A G protein-coupled receptor responsive to bile acids, " The Journal of Biological Chemistry, vol. 278, no. 11, pp. 9435-9440, 2003.
24. M. Watanabe, S. M. Houten, C. Mataki et al. , "Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, " Nature, vol. 439, no. 7075, pp. 484-489, 2006.
25. A. D. Lake, P. Novak, P. Shipkova et al. , "Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease, " Toxicology and Applied Pharmacology, vol. 268, no. 2, pp. 132-140, 2013.
26. T. Sugita, K. Amano, M. Nakano, N. Masubuchi, M. Sugihara, and T. Matsuura, "Analysis of the serum bile acid composition in patients with liver disease determined according to the LCMS/MSmethod, " Hepatology, vol. 58, supplement, p. 151A, 2013.